Manifestations ORL du ­sarcome ­myéloïde [ENT manifestations of myeloid sarcoma]

Details

Ressource 1Request a copy Under embargo until 02/04/2026.
UNIL restricted access
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_96D7FB5E5C47
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Manifestations ORL du ­sarcome ­myéloïde [ENT manifestations of myeloid sarcoma]
Journal
Revue medicale suisse
Author(s)
Belaidi D.S., George M., Ceppi F., Gengler C., Schurmann G.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
02/10/2024
Peer-reviewed
Oui
Volume
20
Number
889
Pages
1761-1764
Language
french
Notes
Publication types: Journal Article ; Case Reports ; English Abstract
Publication Status: ppublish
Abstract
Myeloid sarcoma (MS) is a rare extra-medullary manifestation of acute myeloid leukaemia (AML) in the form of a first manifestation, progression or recurrence. Mostly located in the bones, it has the particularity of reaching the ENT sphere by mimicking common patho-logies, leading to a delay in diagnosis and treatment. The -mastoid involvement that we have encountered in our clinical -practice (clinical vignette) shows the complexity of identifying this pathology, with very few cases reported in the literature. The anamnesis, including a -history of AML, and the clinical examination help to guide the investigations. Targeted imaging, in this case CT/MRI combined with a biopsy of the lesion and a marrow puncture, is used to make the -diagnosis. Treatment with chemotherapy is indicated and rapidly initiated.
Keywords
Humans, Sarcoma, Myeloid/diagnosis, Sarcoma, Myeloid/therapy, Leukemia, Myeloid, Acute/diagnosis, Leukemia, Myeloid, Acute/pathology, Magnetic Resonance Imaging/methods, Male, Tomography, X-Ray Computed
Pubmed
Create date
04/10/2024 16:28
Last modification date
05/10/2024 6:15
Usage data